Fortis Life Sciences Acquires Abcore, A Leader in Nanobody Technologies
Extends company capabilities into nanobody and antibody discovery and development.
WALTHAM, MA – March 2nd, 2022 – Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics.
Brian Kim, Chief Executive Officer of Fortis, remarked on the partnership, “Abcore is a powerful addition to the Fortis portfolio and deepens our antibody product and service capabilities. We are particularly optimistic about the potential of nanobody technologies in therapeutic and diagnostic applications. Our acquisition of Abcore aligns perfectly with Fortis’ goal of partnering with and investing in world-class life sciences companies seeking a strategic growth partner.”
“We are excited about accelerating Abcore’s growth as part of the Fortis family,” added David Barraclough, Chief Executive Officer of Abcore. “Fortis shares our commitment to scientific discovery, innovation, and customer service and is the ideal partner for Abcore as we expand our technical capabilities and bring new products and services to market.” Jennifer Johnson, President of Abcore, also added, “Our partnership with Fortis will provide Abcore with the commercial and operational infrastructure necessary for us to focus on developing high-quality products and better serving our customers.”
Pivotal Scientific Ltd. acted as the exclusive corporate advisor to Abcore.
About Abcore: Abcore, based in San Diego, CA, provides antibody and nanobody products and services. Abcore has built an entire platform for nanobody and single domain (VHH) antibody discovery, based on proprietary phage display libraries. The Company offers end-to-end discovery and development capabilities and custom antibody production. View more at www.abcore.com
About Fortis Life Sciences: Fortis Life Sciences is a strategic platform company providing capital, expertise, and operational resources to enable the growth and success of founder-led life sciences tools companies. Established in 2020 and headquartered in Waltham, Massachusetts, Fortis Life Sciences has a vision of creating a unique life sciences company focused on offering world class products coupled with the best customer experience in the industry. View more at www.fortislife.com